Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis
暂无分享,去创建一个
P. Marino | M. Cicoira | A. Rossi | G. Golia | L. Zanolla | P. Zardini | L. Franceschini | M. Graziani | P. Marino
[1] P. Marino,et al. Can left ventricular diastolic stiffness be measured noninvasively? , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[2] F. Alla,et al. Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.
[3] J. Emparanza,et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. , 2000, Circulation.
[4] S. Jensen,et al. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. , 2000, Circulation.
[5] J. Díez,et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. , 1998, Circulation.
[6] M. Niemelä,et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. , 1997, Circulation.
[7] R. Nishimura,et al. Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous catheterization and Doppler echocardiographic study. , 1997, Journal of the American College of Cardiology.
[8] L. Tavazzi,et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. , 1997, Circulation.
[9] A. Giordano,et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.
[10] J. Thomas,et al. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. , 1995, Circulation.
[11] H. Eichler,et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. , 1995, The American journal of cardiology.
[12] K. Weber,et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. , 1994, Journal of molecular and cellular cardiology.
[13] A. Giordano,et al. Doppler-Derived Mitral Deceleration Time of Early Filling as a Strong Predictor of Pulmonary Capillary Wedge Pressure in Postinfarction Patients with Left Ventricular Systolic Dysfunction , 1994, Journal of the American College of Cardiology.
[14] W. Little,et al. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. , 1994, Circulation.
[15] Noel N Kim,et al. Identification of Functional Angiotensin II Receptors on Rat Cardiac Fibroblasts , 1993, Circulation.
[16] A. di Lenarda,et al. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications , 1993 .
[17] D. Richards. Cardiac catheterization and angiography. 3rd edn. , 1987 .
[18] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[19] William Grossman,et al. Cardiac catheterization and angiography , 1974 .